Let’s explore Morepen Lab share price targets for each year in detail. We will cover targets for 2024, 2025, 2030, and even 2040.
I aim to provide you with expert-based price targets. You can expect clear and concise information about the stock’s future potential.
Follow along as we review each year’s target to offer valuable insights. This article will focus on providing the latest targets based on expert insights.
By understanding Morepen Lab’s (NSE: MOREPENLAB) targets, we can make more informed decisions.
Morepen Lab Share Price Target (2024-2030)
| Year | Minimum Target | Maximum Target |
|---|---|---|
| 2024 | ₹65.50 | ₹98.60 |
| 2025 | ₹77.40 | ₹153.00 |
| 2026 | ₹90.50 | ₹178.40 |
| 2027 | ₹105.80 | ₹207.00 |
| 2028 | ₹122.50 | ₹238.90 |
| 2029 | ₹141.00 | ₹274.10 |
| 2030 | ₹164.40 | ₹316.40 |
Morepen Lab Share Price Target (2035, 2040, 2050)
| Year | Minimum Target | Maximum Target |
|---|---|---|
| 2035 | ₹432.10 | ₹664.00 |
| 2040 | ₹561.30 | ₹843.00 |
| 2050 | ₹783.40 | ₹1,175.10 |
Morepen Lab Share Price Chart
Morepen Lab Percentage Growth Compared to Today’s Price
| Year | Percentage Growth |
|---|---|
| 2024 | 12.05% |
| 2025 | 73.86% |
| 2026 | 102.73% |
| 2027 | 135.23% |
| 2028 | 171.47% |
| 2029 | 211.48% |
| 2030 | 259.55% |
| 2035 | 654.55% |
| 2040 | 858.52% |
| 2050 | 1,234.20% |
Morepen Lab Share Price Target 2024
| Month | Minimum Target | Maximum Target |
|---|---|---|
| October | ₹79.20 | ₹93.50 |
| November | ₹81.50 | ₹96.00 |
| December | ₹83.80 | ₹98.60 |
Morepen Lab Share Price Target 2025
| Month | Minimum Target | Maximum Target |
|---|---|---|
| January | ₹82.30 | ₹123.50 |
| February | ₹83.90 | ₹126.20 |
| March | ₹85.50 | ₹128.80 |
| April | ₹87.10 | ₹131.50 |
| May | ₹88.80 | ₹134.20 |
| June | ₹90.50 | ₹136.80 |
| July | ₹92.20 | ₹139.50 |
| August | ₹93.90 | ₹142.10 |
| September | ₹95.70 | ₹144.80 |
| October | ₹97.50 | ₹147.50 |
| November | ₹99.30 | ₹150.20 |
| December | ₹101.10 | ₹153.00 |
Morepen Lab Share Price Target 2026
| Month | Minimum Target | Maximum Target |
|---|---|---|
| January | ₹96.40 | ₹144.60 |
| February | ₹98.20 | ₹147.60 |
| March | ₹100.10 | ₹150.60 |
| April | ₹102.00 | ₹153.60 |
| May | ₹103.90 | ₹156.70 |
| June | ₹105.80 | ₹159.70 |
| July | ₹107.80 | ₹162.80 |
| August | ₹109.80 | ₹165.90 |
| September | ₹111.90 | ₹169.00 |
| October | ₹114.00 | ₹172.10 |
| November | ₹116.10 | ₹175.20 |
| December | ₹118.20 | ₹178.40 |
Morepen Lab Share Price Target 2027
| Month | Minimum Target | Maximum Target |
|---|---|---|
| January | ₹112.80 | ₹169.20 |
| February | ₹115.00 | ₹172.50 |
| March | ₹117.20 | ₹175.80 |
| April | ₹119.50 | ₹179.20 |
| May | ₹121.70 | ₹182.60 |
| June | ₹124.00 | ₹186.00 |
| July | ₹126.30 | ₹189.40 |
| August | ₹128.70 | ₹192.90 |
| September | ₹131.10 | ₹196.40 |
| October | ₹133.50 | ₹199.90 |
| November | ₹136.00 | ₹203.40 |
| December | ₹138.50 | ₹207.00 |
Morepen Lab Share Price Target 2028
| Month | Minimum Target | Maximum Target |
|---|---|---|
| January | ₹130.40 | ₹195.60 |
| February | ₹133.10 | ₹199.40 |
| March | ₹135.80 | ₹203.20 |
| April | ₹138.60 | ₹207.10 |
| May | ₹141.30 | ₹210.90 |
| June | ₹144.10 | ₹214.80 |
| July | ₹146.90 | ₹218.70 |
| August | ₹149.80 | ₹222.70 |
| September | ₹152.70 | ₹226.70 |
| October | ₹155.70 | ₹230.70 |
| November | ₹158.70 | ₹234.80 |
| December | ₹161.80 | ₹238.90 |
Morepen Lab Share Price Target 2029
| Month | Minimum Target | Maximum Target |
|---|---|---|
| January | ₹150.90 | ₹226.40 |
| February | ₹154.10 | ₹230.60 |
| March | ₹157.30 | ₹234.80 |
| April | ₹160.50 | ₹239.10 |
| May | ₹163.80 | ₹243.30 |
| June | ₹167.10 | ₹247.60 |
| July | ₹170.50 | ₹251.90 |
| August | ₹173.90 | ₹256.30 |
| September | ₹177.30 | ₹260.70 |
| October | ₹180.80 | ₹265.10 |
| November | ₹184.30 | ₹269.60 |
| December | ₹187.80 | ₹274.10 |
Morepen Lab Share Price Target 2030
| Month | Minimum Target | Maximum Target |
|---|---|---|
| January | ₹174.60 | ₹261.90 |
| February | ₹178.30 | ₹266.60 |
| March | ₹182.00 | ₹271.40 |
| April | ₹185.80 | ₹276.20 |
| May | ₹189.50 | ₹281.10 |
| June | ₹193.30 | ₹285.90 |
| July | ₹197.20 | ₹290.90 |
| August | ₹201.10 | ₹295.90 |
| September | ₹205.10 | ₹301.00 |
| October | ₹209.10 | ₹306.10 |
| November | ₹213.20 | ₹311.20 |
| December | ₹217.30 | ₹316.40 |
Morepen Lab Latest Report
| Total Income (latest) | ₹448.62 crore |
| Total Income (previous) | ₹349.69 crore |
| EBITDA (latest) | ₹54.64 crore |
| EBITDA (previous) | ₹21.74 crore |
| EBITDA Growth (YoY) | 151% |
| Net Profit (latest) | ₹31.99 crore |
| Net Profit (previous) | ₹8.99 crore |
| Net Profit Growth (YoY) | 256% |
| Domestic Revenue (latest) | ₹271 crore |
| International Revenue | ₹178 crore |
| EBITDA (latest) | ₹119.97 crore |
| EBITDA (previous) | ₹66.99 crore |
| Net Profit (latest) | ₹67.88 crore |
| Net Profit (previous) | ₹30.43 crore |
| Total Revenues (previous) | ₹1,424 crore |
| Net Profit (previous) | ₹37 crore |
| EBITDA (previous) | ₹86 crore |
| Export to Countries | 80+ countries |
| Patents Granted | 44 |
Morepen Lab Future Plans
| Future Plans | Details |
|---|---|
| Expand API Portfolio | Develop new APIs |
| Focus on New Products | Anti-diabetic & OTC |
| Global Expansion | Increase exports |
| New Products | APIs like Bilastine |
| Strategy for US Market | Regulatory approvals |
| Focus on Cost Efficiency | Control measures |
| Innovate in Formulations | Expanding offerings |
Expert’s Opinion
Based on the latest data, Morepen Lab shows steady growth. The targets reveal increasing potential year by year.
Experts suggest that this stock could perform well in the long term. The company’s focus on innovation and international expansion is a positive sign.
Morepen Lab’s consistent growth in revenue and net profit offers strong fundamentals.
However, like any stock, it is important to monitor market trends regularly. Experts recommend evaluating your investment goals when considering this stock.
To Know The Price Targets Of Other Companies’ Share, You Can Visit Our Price Target Category. For Today’s Best Stock Market News, Please Visit the SarkariCash Website.
FAQs
Is Morepen Lab a good stock to buy in 2024?
With a price target of ₹98.6 for 2024, Morepen Lab shows potential for growth.
What is Morepen Lab share price target for 2024?
Morepen Lab share price is expected to reach ₹98.6 in 2024.
How much could Morepen Lab stock grow by 2025?
By 2025, Morepen Lab stock could grow to ₹153 based on expert targets.
Will Morepen Lab stock double by 2030?
Yes, Morepen Lab stock is expected to more than double by 2030, reaching ₹316.4.
What is Morepen Lab share price target for 2030?
Morepen Lab share price could hit ₹316.4 by 2030.
Can Morepen Lab stock triple by 2040?
Yes, Morepen Lab stock could triple and reach ₹843 by 2040.
What is the long-term share price target for Morepen Lab?
By 2050, Morepen Lab share price could reach ₹1,175.1 as per experts.
Will Morepen Lab stock cross ₹1000 before 2050?
Yes, Morepen Lab stock could exceed ₹1000 before 2050 with a target of ₹1,175.1.
How fast will Morepen Lab stock price grow each year?
Experts predict Morepen Lab stock price will grow between 20 percent to 35 percent annually until 2030.
What factors drive Morepen Lab stock price growth?
Growth is driven by new APIs, international expansion, and strong financial performance.
Could Morepen Lab stock see a price correction?
Yes, minor price corrections are possible but overall long-term growth is expected.
Is Morepen Lab a good long-term investment?
Yes, with a target of ₹1,175.1 by 2050, Morepen Lab is considered a strong long-term investment by experts.
Will Morepen Lab stock double by 2030?
Yes, Morepen Lab stock is expected to more than double by 2030, reaching ₹316.4.
What are the risks of investing in Morepen Lab?
Market fluctuations and competition in the pharmaceutical industry could pose risks.
What is the future plan for Morepen Lab?
Morepen Lab aims to expand its API portfolio and increase exports.
Can Morepen Lab stock reach ₹500 before 2040?
Yes, Morepen Lab stock is expected to exceed ₹500 by 2040.
Disclaimer: This information is not financial advice. Stock price targets may change based on market trends. Please research or consult a financial advisor before investing.
